Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 43 min 3 sec ago

Escalon(R) Medical Corp. Enters Agreement to Distribute Diaton Tonometer

Fri, 04/25/2014 - 14:59
The Diaton Tonometer joins Sonomed Escalon's VuPad™ at ASCRS Booth 873 ARDMORE, Pa., April 25, 2014 -- (Healthcare Sales & Marketing Network) -- Escalon Medical Corp. (ESMC) today announced that it has entered into a distribution agreement with Long Be...
Devices, Ophthalmology, Distribution
Escalon Medical, BiCOM, transpalpebral, tonometer, intraocular pressure

Volcano Announces Limited Market Release of SyncVision(TM) Technology System

Fri, 04/25/2014 - 14:53
New system allows co-registration of angiography with intravascular imaging (IVUS) SAN DIEGO, April 25, 2014 -- (Healthcare Sales & Marketing Network) -- Volcano Corporation (VOLC), a leading developer and manufacturer of precision guided therapy tools...
Devices, Interventional Cardiology, Product Launch
Volcano, SyncVision, imaging, IVUS

Orthofix Appoints James F. Hinrichs to its Board of Directors

Fri, 04/25/2014 - 14:50
Mr. Hinrichs to Become Chair of Audit and Finance Committee LEWISVILLE, Texas--(Healthcare Sales & Marketing Network)--Orthofix International N.V. (OFIX) announced today that it has appointed James F. Hinrichs to its Board of Directors, effective immedi...
Devices, Orthopaedic, Personnel

Chugai Pharma USA Announces Appointment of Chief Medical Officer

Fri, 04/25/2014 - 14:46
BERKELEY HEIGHTS, N.J. and TOKYO, April 25, 2014 -- (Healthcare Sales & Marketing Network) -- Chugai Pharma USA, LLC (CPUSA), Berkeley Heights, NJ a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd. (Chugai) Tokyo, Japan, member of the Roche Grou...
Biopharmaceuticals, Personnel
Chugai Pharmaceutical

FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer

Thu, 04/24/2014 - 19:54
Expanded indication makes cobas® HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older PLEASANTON, Calif., April 24, 2014 -- (Healthcare Sales & Marketing Network) -- Roche (SI...
Diagnostics, Oncology, FDA
Roche Group, cobas HPV Test, Papillomavirus, cervical cancer

Grafix(R) Pharmacoeconomic and Scientific Characterization Studies Featured at the 2014 Spring Symposium for Advanced Wound Care

Thu, 04/24/2014 - 15:12
COLUMBIA, Md.--(Healthcare Sales & Marketing Network)--Osiris Therapeutics, Inc. (OSIR) announced today that results from both a pharmacoeconomic evaluation and a scientific characterization (cryopreservation versus non-cryopreservation) of Grafix® wil...
Devices, Regenerative Medicine, Wound Care
Osiris Therapeutics, Grafix, stem cell, diabetic foot ulcer

Celgene Acquires Late-Stage Product for Crohn’s Disease and Other Gastrointestinal Disorders

Thu, 04/24/2014 - 15:08
GED-0301 is a First-in-Class, Oral Antisense Drug Targeting Smad7 mRNA Phase III Program for Crohn’s Disease Targeted to Begin by Year-End 2014 SUMMIT, N.J.--(Healthcare Sales & Marketing Network)--Celgene Corporation (CELG) entered into a global li...
Biopharmaceuticals, Gastroenterology, Licensing
Celgene, Nogra Pharma, antisense, Crohn’s disease

Endo Acquires Rights to Sumavel(R) DosePro(R)

Thu, 04/24/2014 - 15:04
Addition of product to Specialty Pharmaceuticals portfolio expected to be immediately accretive to adjusted diluted earnings per share Product to be commercialized by current Endo Branded Pharmaceutical team Expands portfolio of branded products in t...
Biopharmaceuticals, Drug Delivery, Acquisitions
Endo International, Zogenix, Sumavel, DosePro, sumatriptan, migraine

Steve Gex Named CEO at Focal Therapeutics

Wed, 04/23/2014 - 21:39
Well Known Leader of Medical Device Companies Brings His Expertise to Maker of BioZorb Surgical Marker PORTOLA VALLEY, Calif.--(Healthcare Sales & Marketing Network)--Steve Gex, an accomplished leader of several medical-device companies in women's healt...
Devices, Personnel
Focal Therapeutics, BioZorb

Jeffrey Gold Joins myoscience as President and Chief Operating Officer

Wed, 04/23/2014 - 13:18
REDWOOD CITY, Calif., April 23, 2014 -- (Healthcare Sales & Marketing Network) -- myoscience, inc. is pleased to announce the addition of Jeffrey Gold to the team as President and Chief Operating Officer (COO). Mr. Gold is an accomplished executive, having...
Devices, Personnel
myoscience, Focused Cold Therapy

Spectrum Pharmaceuticals’ Pivotal Trial of Captisol-Enabled(TM) (Propylene Glycol-Free) Melphalan Meets Primary Endpoint

Wed, 04/23/2014 - 13:13
CE Melphalan is being developed as a novel version of the well-established conditioning treatment in autologous transplant for patients with multiple myeloma. CE Melphalan does not contain propylene glycol, an ingredient in currently available products whi...
Biopharmaceuticals, Oncology
Spectrum Pharmaceuticals, CE Melphalan, Captisol-enabled, Melphalan

The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio

Wed, 04/23/2014 - 13:07
Acquires Tenaxis Medical, Inc. PARSIPPANY, NJ and MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - The Medicines Company (NASDAQ: MDCO) and Tenaxis Medical, Inc. (Tenaxis) today announced an agreement for The Medicines Company to acquire Tena...
Devices, Surgery, Mergers & Acquisitions
The Medicines Company, Tenaxis Medical, surgical sealant

Kala Pharmaceuticals Announces $22.5 Million Series B Financing

Wed, 04/23/2014 - 13:01
Ysios Capital Joins as Lead Investor; Proceeds to Advance Four U.S. Clinical Trials for Lead Ophthalmic Product Candidates WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--Kala Pharmaceuticals, Inc., a leading developer of innovative ophthalmic p...
Biopharmaceuticals, Ophthalmology, Venture Capital
Kala Pharmaceuticals

OncoSec Medical Names Adil Daud, M.D. as Chief Clinical Strategist

Wed, 04/23/2014 - 12:55
Company Appoints Nationally Renowned Expert in Targeted Therapies for Melanoma to Clinical Leadership Role SAN DIEGO--(Healthcare Sales & Marketing Network)--OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based immunotherap...
Biopharmaceuticals, Oncology, Personnel
OncoSec Medical, ImmunoPulse

Avedro Announces Canadian Approval for its KXL II (TM) Advanced Cross-Linking System

Wed, 04/23/2014 - 12:50
Offering the Potential for a Non-Surgical Alternative to LASIK WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company...
Devices, Ophthalmology, Regulatory
Avedro, KXL II System, Photorefractive Intrastromal Cross-Linking

Surefire Medical's Groundbreaking COSY Clinical Trial Results Presented at ECIO: Is Coiling Prior to Radioembolization Still Necessary in Minimally Invasive Treatment of Liver Cancer?

Wed, 04/23/2014 - 12:46
Results: Fluoroscopy time reduced by 70%; Procedure Time, Contrast Dose Cut 50% WESTMINSTER, Colo., April 23, 2014 -- (Healthcare Sales & Marketing Network) -- Surefire Medical, Inc. announced that a symposium focused on the Coiling vs. Surefire Infusi...
Devices, Interventional, Oncology
Surefire Medical, Selective Internal Radiation Therapy, SIRT , Surefire Infusion

Smiths Medical Launches Pneupac(R) paraPAC plus(TM) in U.S. and Canada

Tue, 04/22/2014 - 13:29
Pneupac® paraPAC plus™ provides advanced transport ventilation and CPAP assistance from pre-hospital to hospital including the MRI suite ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--Smiths Medical, a leading global medical device manufac...
Devices, Product Launch
Smiths Medical, Pneupac, paraPAC plus, ventilator

Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis

Tue, 04/22/2014 - 13:21
OPT Pivotal #1 and OPT Pivotal #2 Studies, Together with Three Other Phase 3 Trials, to Form Basis for Planned Psoriasis Indication Submission to Regulatory Authorities NEW YORK--(Healthcare Sales & Marketing Network)--Pfizer Inc. (PFE) announced today ...
Biopharmaceuticals, Dermatology
Pfizer, Psoriasis, tofacitinib, JAK inhibitor, XELJANZ

Cellnovo Strengthens Senior Management Team with Three Key Hires

Tue, 04/22/2014 - 13:11
Creates Cellnovo France SWANSEA, Wales, April 22, 2014 -- (Healthcare Sales & Marketing Network) --Cellnovo, the leading innovator in Mobile Diabetes Management and insulin patch pump technologies, announces the appointments of three experienced execut...
Devices, Endocrinology, Personnel
Cellnovo, Mobile Diabetes Management

Aperion Biologics, Inc. Granted CE Mark for Z-Lig ACL Replacement Device

Tue, 04/22/2014 - 13:05
Off-the shelf biologic medical device is now approved and poised for introduction in the EU for use in certain anterior cruciate ligament (ACL) knee surgeries SAN ANTONIO, Texas, April 22, 2014 -- (Healthcare Sales & Marketing Network) -- Aperion Biolo...
Devices, Orthopaedic, Regulatory
Aperion Biologics, Z-Lig, ACLR device, ACL knee reconstruction

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong